Department of Pathology and Medical Biology, Division of Pathology (R.M., H.v.G., J.L.H.), University Medical Center Groningen, the Netherlands.
Department of Cardiology (L.A.A., M.-S.L.Y.d.K., D.J.v.V., P.v.d.H., E.L.), University Medical Center Groningen, the Netherlands.
Arterioscler Thromb Vasc Biol. 2024 Aug;44(8):1884-1894. doi: 10.1161/ATVBAHA.124.320974. Epub 2024 Jun 20.
Vascular calcification is associated with increased mortality in patients with cardiovascular disease. Secondary calciprotein particles are believed to play a causal role in the pathophysiology of vascular calcification. The maturation time (T) of calciprotein particles provides a measure of serum calcification propensity. We compared T between patients with ST-segment-elevated myocardial infarction and control subjects and studied the association of T with cardiovascular risk factors and outcome.
T was measured by nephelometry in 347 patients from the GIPS-III trial (Metabolic Modulation With Metformin to Reduce Heart Failure After Acute Myocardial Infarction: Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction: a Randomized Controlled Trial) and in 254 matched general population controls from PREVEND (Prevention of Renal and Vascular End-Stage Disease). We also assessed the association between T and left ventricular ejection fraction, as well as infarct size, the incidence of ischemia-driven reintervention during 5 years of follow-up, and serum nitrite as a marker of endothelial dysfunction.
Patients with ST-segment-elevated myocardial infarction had a significantly lower T (ie, higher serum calcification propensity) compared with controls (T: 289±63 versus 338±56 minutes; <0.001). In patients with ST-segment-elevated myocardial infarction, lower T was associated with female sex, lower systolic blood pressure, lower total cholesterol, lower LDL (low-density lipoprotein) cholesterol, lower triglycerides, and higher HDL (high-density lipoprotein) cholesterol but not with circulating nitrite or nitrate. Ischemia-driven reintervention was associated with higher LDL (=0.03) and had a significant interaction term for T and sex (=0.005), indicating a correlation between ischemia-driven reintervention and T above the median in men and below the median in women, between 150 days and 5 years of follow-up.
Serum calcification propensity is increased in patients with ST-segment-elevated myocardial infarction compared with the general population, and its contribution is more pronounced in women than in men. Its lack of/inverse association with nitrite and blood pressure confirms T to be orthogonal to traditional cardiovascular disease risk factors. Lower T was associated with a more favorable serum lipid profile, suggesting the involvement of divergent pathways of calcification stress and lipid stress in the pathophysiology of myocardial infarction.
血管钙化与心血管疾病患者的死亡率增加有关。钙磷蛋白次级颗粒被认为在血管钙化的病理生理学中起因果作用。钙磷蛋白颗粒的成熟时间(T)提供了血清钙化倾向的衡量标准。我们比较了 ST 段抬高型心肌梗死患者和对照组之间的 T,并研究了 T 与心血管危险因素和预后的关系。
在 GIPS-III 试验(二甲双胍代谢调节以降低急性心肌梗死后心力衰竭:ST 段抬高型心肌梗死中糖代谢干预作为主要冠状动脉介入治疗的辅助治疗:一项随机对照试验)的 347 名患者和 PREVEND(预防肾脏和血管终末期疾病)的 254 名匹配的一般人群对照中,通过散射比浊法测量了 T。我们还评估了 T 与左心室射血分数以及梗死面积、5 年随访期间缺血驱动再干预的发生率之间的关系,以及血清亚硝酸盐作为内皮功能障碍的标志物。
与对照组相比,ST 段抬高型心肌梗死患者的 T 明显较低(即血清钙化倾向较高)(T:289±63 与 338±56 分钟;<0.001)。在 ST 段抬高型心肌梗死患者中,较低的 T 与女性、较低的收缩压、较低的总胆固醇、较低的 LDL(低密度脂蛋白)胆固醇、较低的甘油三酯和较高的 HDL(高密度脂蛋白)胆固醇相关,但与循环亚硝酸盐或硝酸盐无关。缺血驱动的再干预与 LDL 相关(=0.03),并且 T 和性别之间存在显著的交互项(=0.005),这表明在男性中,缺血驱动的再干预与 T 的相关性高于中位数,而在女性中则低于中位数,在 150 天至 5 年的随访期间。
与一般人群相比,ST 段抬高型心肌梗死患者的血清钙化倾向增加,并且其在女性中的作用比男性更为显著。其与亚硝酸盐和血压的缺乏/负相关证实 T 与传统心血管疾病危险因素正交。较低的 T 与更有利的血清脂质谱相关,这表明钙化应激和脂质应激的不同途径在心肌梗死的病理生理学中起作用。